Convergent Regulation of Neuronal Differentiation and Erk and Akt Kinases in Human Neural Progenitor Cells by Lysophosphatidic Acid, Sphingosine 1-Phosphate, and LIF: Specific Roles for the LPA1 Receptor

Phillip Callihan, Mourad W. Ali, Hector F. Salazar, Nhat D. Quach, Xian Wu, Steven L. Stice, Shelley B. HooksASN 2014 · DOI

TL;DR

This study reveals that the signaling lipids LPA and S1P promote the survival of human neural progenitor cells (hNPs) while simultaneously inhibiting their differentiation into neurons. Crucially, the LPA1 receptor plays a key role in these effects, and cross-talk with the cytokine LIF significantly modulates LPA/S1P signaling, impacting both cell survival and neuronal marker expression.

What Problem Does This Paper Address?

The developing nervous system relies on a complex interplay of signaling molecules to guide the growth and differentiation of neural progenitor cells (NPCs). Lysophospholipids, such as lysophosphatidic acid (LPA) and sphingosine-1-phosphate (S1P), are known to influence various cellular processes, including proliferation, survival, and differentiation. However, the precise molecular mechanisms by which these lipids regulate neuronal differentiation, especially in human systems, remain poorly understood. Previous studies have shown conflicting results, with some suggesting LPA promotes neuronal differentiation in rodent models, while others indicate it inhibits it in human models. This paper aims to clarify the role of LPA and S1P in human neural progenitor cell (hNP) differentiation and to elucidate the signaling pathways and receptor subtypes involved, particularly focusing on the LPA1 receptor and its interaction with other key signaling pathways like those mediated by LIF.

Methods

The researchers utilized a combination of established and advanced techniques:

  • Cell Culture: Human neural progenitor cells (hNPs) were cultured and differentiated under specific conditions, including withdrawal of basic fibroblast growth factor (bFGF) and the addition of LPA, S1P, or LIF.
  • Cell Viability and Proliferation Assays: CellTiter-Blue® reagent was used to assess metabolic activity (viability), and DAPI staining followed by automated image analysis was employed to quantify cell numbers. Ki-67 staining was used to assess proliferation.
  • Immunofluorescence Microscopy and High-Content Screening: Cells were stained for neuronal markers like βIII-tubulin (Tuj) and Map2. Automated image analysis (Cellomics platform) was used to quantify the expression of these markers and to analyze neurite outgrowth and length.
  • Western Blotting: This technique was used to assess the phosphorylation status of key signaling proteins, specifically Erk and Akt, to understand their activation states in response to different treatments.
  • Quantitative Real-Time PCR (qPCR): This method was used to measure the mRNA expression levels of neuronal differentiation markers, providing insights into gene regulation.
  • Receptor Antagonist Studies: The LPA1 receptor-selective antagonist Ki16425 was used to investigate the specific role of the LPA1 receptor in mediating LPA's effects. Pertussis toxin (Ptx) was used to probe the involvement of Gi-coupled receptors.

Datasets

Not discussed in the paper. The study relies on experimental data generated from cell cultures and molecular assays.

Key Insights and Ideas

  • LPA and S1P as Survival Promoters and Differentiation Inhibitors: Contrary to some previous findings in rodent models, LPA and S1P were found to enhance the survival of human neural progenitor cells while inhibiting their differentiation into neurons. This highlights species-specific differences in lysophospholipid signaling.
  • The Crucial Role of the LPA1 Receptor: The LPA1 receptor emerged as a critical mediator of LPA's effects. Blocking LPA1 with the antagonist Ki16425 not only reversed LPA's inhibitory effects on neuronal differentiation but also significantly enhanced neurite outgrowth, even in the absence of exogenous LPA. This suggests an endogenous tone of LPA1 signaling that promotes cell survival and potentially suppresses differentiation.
  • Opposing Effects on Erk and Akt Pathways: LPA and S1P robustly activated the Erk (MAPK) pathway, known for its role in cell survival and growth, but surprisingly, they strongly suppressed Akt phosphorylation, a pathway often associated with differentiation. This opposing regulation creates a significant shift in the balance of these key signaling cascades.
  • Distinct G-Protein Coupling for Erk and Akt Regulation: The differential effects of Ki16425 and pertussis toxin on Erk and Akt signaling suggest that LPA's activation of Erk is mediated by LPA1 and Gi-coupled pathways, while its inhibition of Akt is likely mediated by a different receptor subtype and/or G-protein coupling.
  • Synergy with LIF: The cytokine LIF significantly amplified the effects of LPA and S1P. Specifically, LIF enhanced the inhibitory effect of LPA/S1P on Akt phosphorylation and, conversely, blunted the activation of Erk by LPA/S1P. This indicates a complex cross-talk between lysophospholipid and cytokine signaling pathways that fine-tunes neuronal differentiation.

Key Results

  • LPA and S1P significantly increased hNP cell survival and decreased neuronal marker expression (βIII-tubulin and Map2) during differentiation.
  • The LPA1 antagonist Ki16425 completely blocked LPA's effects on neuronal differentiation and significantly enhanced neurite length.
  • LPA and S1P strongly activated Erk phosphorylation but inhibited Akt phosphorylation.
  • Ki16425 and pertussis toxin blocked LPA-induced Erk activation but did not affect LPA-induced Akt inhibition.
  • LIF treatment alone increased cell viability but not cell number, suggesting enhanced metabolic activity rather than proliferation.
  • LIF co-treatment with LPA/S1P amplified the inhibition of Akt phosphorylation and blunted Erk activation.
  • qPCR analysis confirmed that LPA and S1P inhibited the mRNA expression of neuronal markers (Tuj, Map2, HuC, HuD, ChAT) specifically in the presence of LIF.

Limitations and Future Work

  • Off-Target Effects of Inhibitors: While Ki16425 is a selective LPA1 antagonist, the authors acknowledge the potential for off-target effects of pharmacological inhibitors. Attempts to confirm LPA1's role via knockdown were unsuccessful due to low transfection rates and the inhibitory effects of LPA1 loss on cell growth.
  • Endogenous LPA Signaling: The study suggests a possible endogenous tone of LPA1 receptor activity, evidenced by Ki16425's effects on survival and neurite extension even without exogenous LPA. Further investigation is needed to fully define this autocrine/paracrine signaling.
  • S1P Receptor Specificity: While S1P showed similar effects to LPA, the specific receptor subtypes mediating these actions (beyond the general involvement of Gi) were not fully elucidated. The antagonist VPC23019 did not consistently block S1P's effects, suggesting other S1P receptors, like S1P2, might be involved in hNPs.
  • Rho/ROCK Pathway Involvement: The paper briefly mentions that Rho/ROCK pathways are critical for neuronal differentiation in other systems and suggests future studies should investigate their role in LPA's effects on hNPs.
  • LIF Signaling Complexity: The study highlights the significant impact of LIF but notes that chronic exposure to LIF might alter its signaling. Further work is needed to fully define LIF's role in hNP differentiation and survival.
  • Species and Model Differences: The authors emphasize that LPA's effects can vary significantly between different cell types and species, suggesting that receptor expression profiles and interactions with other signaling pathways (like LIF) are key determinants of its pleiotropic actions. Future research should continue to explore these differences.

Summary updated

Abstract

The bioactive lysophospholipids lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P) have diverse effects on the developing nervous system and neural progenitors, but the molecular basis for their pleiotropic effects is poorly understood. We previously defined LPA and S1P signaling in proliferating human neural progenitor (hNP) cells, and the current study investigates their role in neuronal differentiation of these cells. Differentiation in the presence of LPA or S1P significantly enhanced cell survival and decreased expression of neuronal markers. Further, the LPA receptor antagonist Ki16425 fully blocked the effects of LPA, and differentiation in the presence of Ki16425 dramatically enhanced neurite length. LPA and S1P robustly activated Erk, but surprisingly both strongly suppressed Akt activation. Ki16425 and pertussis toxin blocked LPA activation of Erk but not LPA inhibition of Akt, suggesting distinct receptor and G-protein subtypes mediate these effects. Finally, we explored cross talk between lysophospholipid signaling and the cytokine leukemia inhibitory factor (LIF). LPA/S1P effects on neuronal differentiation were amplified in the presence of LIF. Similarly, the ability of LPA/S1P to regulate Erk and Akt was impacted by the presence of LIF; LIF enhanced the inhibitory effect of LPA/S1P on Akt phosphorylation, while LIF blunted the activation of Erk by LPA/S1P. Taken together, our results suggest that LPA and S1P enhance survival and inhibit neuronal differentiation of hNP cells, and LPA1 is critical for the effect of LPA. The pleiotropic effects of LPA may reflect differences in receptor subtype expression or cross talk with LIF receptor signaling.
BibTeX
@inproceedings{callihan2014convergent,
  author = {Phillip Callihan and Mourad W. Ali and Hector F. Salazar and Nhat D. Quach and Xian Wu and Steven L. Stice and Shelley B. Hooks},
  title = {{Convergent Regulation of Neuronal Differentiation and Erk and Akt Kinases in Human Neural Progenitor Cells by Lysophosphatidic Acid, Sphingosine 1-Phosphate, and LIF: Specific Roles for the LPA1 Receptor}},
  booktitle = {ASN},
  year = {2014},
  doi = {10.1177/1759091414558416},
}
Figure